Pharmacotherapy and COVID-19 - Part 1 - Consumers respond
Description
Pharmacotherapy is a treatment for opioid dependence that plays a vital role in many Victorians' lives.
In response to COVID-19, a number of changes were made to the way it is delivered. Some of these changes had profound effects on peoples' lives, and there is ongoing debate as to which, if any, should be kept beyond the pandemic period.
For part 1 we get a firsthand view of the changes from a group of consumers.
Please also check out part 2 for an interview with Sarah Lord, who works at Pharmacotherapy Advocacy, Mediation & Support, a service of Harm Reduction Victoria. Sarah provides both detail and overview, and this may be a good place to start if you're new to the topic.
The show is brought to you by the Association of Participating Service Users (APSU), which is a service of the Self Help Addiction Resource Centre (SHARC).
APSU is a Victorian consumer body that believes the voices of people with lived experience of AOD issues should be heard and incorporated into service design and delivery.
The views expressed in this podcast are not necessarily the views of APSU or SHARC. Names and identifying details may have been changed for privacy reasons.
Music is by dbh. There’s plenty more of it here.